Large-scale testing (Phase 3)Study completedNCT01416636
What this trial is testing
Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
Who this might be right for
Non-operable Chronic Thromboembolic Pulmonary Hypertension
SciPharm SàRL 105